Screener
Revvity RVTY Diagnostics — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
FAQ
- What is Revvity's diagnostics — depreciation?
- Revvity (RVTY) reported diagnostics — depreciation of $9.56M in Q1 2026.
- How has Revvity's diagnostics — depreciation changed year-over-year?
- Revvity's diagnostics — depreciation increased by 39.6% year-over-year, from $6.85M to $9.56M.
- What is the long-term trend for Revvity's diagnostics — depreciation?
- Over 3 years (2022 to 2025), Revvity's diagnostics — depreciation has grown at a 3.7% compound annual growth rate (CAGR), from $29.94M to $33.4M.
- What does diagnostics — depreciation mean?
- The systematic allocation of the cost of tangible assets over their useful lives within the diagnostics segment. This non-cash charge reflects the wear and tear of machinery, laboratory equipment, and facilities used in operations.
Ask your AI about Revvity's diagnostics — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude